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Fighting against Oneself
PAGE 1133
Ideally, treatments for autoimmune disorders
would specifically target the autoantigen-recog-
nizing B and T cells that drive the disease.
However, this is not possible and current thera-
pies either shut down the immune response glob-
ally, with serious consequences, or simply treat
the associated inflammatory symptoms. Here,
Gocke et al. present a combinatorial library
screening strategy that allows for the isolation of
compounds that target autoantigen-recognizing
T cells with high specificity. The authors show
that a compound derived from a screen targeted
tomurine autoimmune T cells that drive amultiple sclerosis-like disease can be selectively inactivated. This tech-
nology provides proof of principle for the development of therapeutic reagents that attack undesirable immune
cells with unprecedented specificity.
E1 Elimination from Green to Red
PAGE 1140
Photoconvertible fluorescent proteins change their emissions from green to red when exposed to ultraviolet light.
This process occurs via a b-elimination reaction that causes cleavage of the Na-Ca bond of a histidine residue
and subsequent extension of a p-conjugated system. By comparing green and red states of an engineered pho-
toconvertible fluorescent protein, KikGR, and analyzing the crystal structures of each, Tsutsui et al. discovered
rotation along the Ca-Cb bond of the histidine following cleavage of the Na-Ca bond. The structural rearrange-
ment enhances overall understanding of the mechanisms for the photoconversion that couples processes of
photoexcitation and b-elimination reactions within a protein cavity.
‘‘Lariat’’ Peptide Inhibitors of Protein Function
PAGE 1148
Reverse genetic approaches, although extremely useful, are diffi-
cult to perform on a large scale and in diploid organisms. Barreto
et al. now describe development of technology for generating
‘‘lariat’’ peptide inhibitors. Lariats consist of a lactone-cyclized
peptide ‘‘noose’’ with a covalently attached peptide ‘‘handle.’’
The versatile handle provides lariats with many advantages over
‘‘head-to-tail’’ cyclized peptides. For example, functional domains
can be inserted into the handle that allows combinatorial libraries
of lariats to be screened using genetic assays. Affinity tags and flu-
orophores can also be attached to the handle during chemical
synthesis. Further, the small size of lariats allows their structures
to be easily solved and makes them useful as drugs or drug leads.
SMIFH2 Puts a Stop to Actin Assembly
PAGE 1158
Actin filament assembly stimulated by formins is critical for cells. However, the contributions of multiple formin
isoforms for different processes in a variety of cell types are unclear. Here, Rizvi et al. describe the identification
and characterization of a small molecule inhibitor of formin-mediated actin assembly. SMIFH2 targets formins
from evolutionarily diverse organisms including yeast, nematode worm, and mice. SMIFH2 blocks both for-
min-mediated actin filament nucleation and elongation and disrupts formin-dependent actin structures in fission
yeast and mammalian cells. Therefore, SMIFH2may be a useful drug for elucidating formin-mediated processes
in a range of organisms.
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Autofluorescent Proteins at Sea
PAGE 1169
Despite their ubiquitous use as experimental tools in cell biology and
invertebrate organisms, fluorescent proteins have seen only limited
use for whole-body imaging in animals. This is partly because existing
fluorescent proteins are inefficiently excited at the red wavelengths of
the optical window away from hemoglobin absorbance. Lin et al.
report the development of a monomeric far-red fluorescent protein
named mNeptune that can excited in the optical window. A detailed
structural characterization also reveals the chemical mechanism by
which mNeptune achieves its red-shifted excitation spectrum.
Building the Bridge of Bacterial Destruction
PAGE 1180
Hygromycin A (HA) is an antibacterial compound isolated from Strep-
tomyces that acts via inhibiting protein synthesis and depends on the
presence of a methylenedioxy bridged-aminocyclitol moiety. Palaniappan et al. now investigate roles that gene
products of HA gene cluster play in the process of HA biosynthesis. The authors show that Hyg18 and Hyg25 are
dispensable for HA biosynthesis but contribute to antibiotic yields. On the other hand, Hyg8 and Hyg17 are
essential for HA biosynthesis. Specifically, they establish that Hyg6 is a methyltransferase acting on the amino-
cyclitol and suggest that hyg7 gene product, homologous to a metallo-dependant hydrolases, catalyzes oxida-
tive cyclization step of methylenedioxy bridge formation. The authors argue that the existence and function of
Hyg7 implies a unique enzymatic strategy for biosynthesis of these unusual bridge moieties.
Across the Membrane and into the Signaling Cascade
PAGE 1190
A negatively charged phospholipid, phosphatidylinositol, occurs in
cells in a variety of phosphorylated forms that are called phosphoino-
sitides. These lipidmolecules with varying numbers of phospho groups
play important roles in cell and lipid signaling and membrane traf-
ficking. The work by Laketa et al. demonstrates that membrane-
permeable phosphoinositide derivatives including a novel phosphoi-
nositide analog with a phosphate on the 6-OH position are suitable
for rapidly activating intracellular signaling events downstream of
PI3K, such as Akt, MAPkinase, and p70S6 kinase. This makes them
important tools to investigate the contribution of phosphoinositide
signaling in living cells. This is demonstrated by the initiation and
modulation of complex PI3K-dependent processes such as neurite
outgrowth of PC12 cells.
Polyketide Synthases Start Your Engines
PAGE 1197
Hedamycin is an antitumor polyketide antibiotic with unusual biosynthetic features. In this work, Khosla et al.
demonstrate that initiation of hedamycin biosynthesis requires interplay between type I and type II polyketide
synthases. The role of individual protein components from the different synthase types was investigated through
in vitro and in vivo experiments, and the resulting insights were parlayed into the engineered biosynthesis of new
‘‘unnatural’’ natural products.
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